Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
Pharma channel feed
Is there room for MASH drugs in a GLP-1 world?
6 months ago
R&D
In Focus
Viking's oral weight loss drug appears to have strong effect in Phase 1 trial
6 months ago
R&D
Novo adds to Wegovy’s cardio strength with hospital admissions analysis
6 months ago
BMS, J&J and AstraZeneca plea with appeals court to overturn drug price negotiations
6 months ago
Law
Heritage and Apotex to pay $49.1M in price-fixing settlement
6 months ago
Law
Q&A with Obesity Society’s CEO as the field prepares for next-gen meds
6 months ago
Teva fined €462.6M by European regulators over Copaxone patent and competition allegations
6 months ago
Law
Federal court backs FDA's approval of competitor to Jazz's sleep drug
6 months ago
FDA+
Law
‘Imitation is best form of flattery’: Regeneron CEO comments on Amgen’s Eylea biosimilar
6 months ago
R&D
Gardasil demand in China sinks, and Merck expects the same next quarter
6 months ago
China
Takeda says multiyear restructuring is 'on track'
6 months ago
R&D
Argenx reports Vyvgart sales streak, bolstered by launch in rare neuro disorder
6 months ago
AbbVie adds to T cell engager momentum, with EvolveImmune pact starting at $65M
6 months ago
Startups
Deals
Bristol Myers ups revenue guidance again, raising confidence in cost-cutting
6 months ago
AbbVie’s immunology blockbusters make up for Humira sales drop in Q3
6 months ago
Hints of impatience grow with Biogen as it tries to find a bridge to growth
6 months ago
R&D
Biogen signs molecular glue deal, raises yearly projections
6 months ago
Deals
R&D
Updated: Lilly’s shares tank after trimming revenue guidance. It also cut three assets
6 months ago
GSK remains ‘very confident’ in RSV vaccine amid competition, sales slump
6 months ago
Pfizer shares new details on obesity pipeline, hints at ‘other opportunities’
6 months ago
R&D
Biopharma begins to contemplate an RFK Jr.-influenced FDA if Trump wins
6 months ago
FDA+
Lexicon's once-rejected diabetes drug is questioned again by FDA ahead of adcomm
6 months ago
FDA+
Novartis expands Scemblix label to first-line CML patients
6 months ago
FDA+
Shionogi touts topline data for Covid-19 antiviral for post-exposure treatment
6 months ago
R&D
First page
Previous page
25
26
27
28
29
30
31
Next page
Last page